Published in AIDS Weekly, August 13th, 2001
The new study was presented July 9, 2001, at the International AIDS Society (IAS) conference.
Epivir and emtricitabine (Triangle/Abbott) are structurally similar nucleoside reverse transcriptase inhibitors that previously have been compared in a limited number of in vitro studies. The study presented at the conference compared the two drugs using three different cell types,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.